Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Although, not the most common form of cardiovascular disease, aortic disease is also considered a disorder of the aorta (the main artery that supplies blood from the heart) can be extremely life threatening. Aneurysms, tears in the inner lining, and penetrating ulcers are all types of aortic diseases that require treatment.
At Stanford, researchers, physicians, and surgeons in many disciplines collaborate together on aortic diseases. The combined work of experts in cardiology, cardiothoracic surgery, cardiovascular anesthesia, interventional radiology, and genetics help determine the causes of aortic diseases, such as thoracic aortic aneurysm, and aortic dissection and to find safer treatments.
Researchers are finding new ways to protect vital organs during aortic surgery, exploring genetic mutations to develop ways to screen family members for aortic problems, and isolating the genetic markers that may indicate a person's susceptibility to the disease.
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.